Biotech

All Articles

A nearer look at Strong Biotech's Ferocious 15

.Within this week's incident of "The Top Line," our team are actually diving in to Strong Biotech's ...

Lilly encounters period 2 breakdown of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's gathering celebrating the approval of...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable leadership hirings, firings as w...

Lykos will inquire FDA to rethink its choice complying with turndown of MDMA therapy for post-traumatic stress disorder

.Observing an unsatisfactory revealing for Lykos Rehabs' MDMA candidate for post-traumatic stress di...

AN 2 fifty percents census, quits phase 3 trial after information disappoint

.AN2 Therapeutics is actually re-thinking its company in reaction to uninspired midphase information...

Merck spends $700M for bispecific, snooping autoimmune opening as well as opportunity to test Amgen in cancer cells

.Merck &amp Co. is paying for $700 thousand ahead of time to challenge Amgen in a blood cancer cells...

Gilead pays for J&ampJ $320M to leave licensing offer for seladelpar

.With Gilead Sciences on the verge of an FDA selection for its liver disease medicine seladelpar, th...

' All palms on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks can easily observe the business setting up camping tents at bas...

Entero laying off personnel, abandoning workplace and stopping R&ampD

.Bed Liquidators has actually transformed Entero Therapeutics white as a piece. The lender bought En...

Exelixis drops ADC after determining it's no match for Tivdak

.Exelixis is quiting on its own tissue aspect (TF)- targeting antibody-drug conjugate after wrapping...